This can be explained by the TGF-β-mediated upregulation of PD-L1 and downregulation of HLA-I in tumor models as shown by us and various reports [42–48] suggesting the involvement of FAP in shaping the immune-suppressive TME landscape. This evidence concerns the gene CD274 and neoplasm.